Warning: The NCBI web site requires JavaScript to function. more...
Institut Pasteur, 25-28 rue du Dr Roux, Paris 75724 Cedex 15, France. mhommel@pasteur.fr
Artemisinins are the most important anti-malarial drugs in use today, but are more costly than previous anti-malarials and production and price tend to fluctuate. Alternative ways of producing artemisinins are discussed here in the light of a recent paper in BMC Biotechnology on improving the yield of the precursor, artemisinic acid, in genetically engineered yeast.
Images from this publication.See all images (2) Free text
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on